NT
Neonc Technologies Holdings, Inc.
NTHI · NASDAQ
$3.33 +1.52% (+$0.05)
1M -29.00%
Market Cap $86.4M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
100 /100
Growing Rev. growth 25.98%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
57 /100
Average ROIC 229.42%
ROA 902.18%
Asset turnover 0.00x
Debt
0 /100
High Current ratio 0.14x
Int. coverage -12.99x
Debt/Equity N/A
Stability
19 /100
Unstable Beta 0.50x
Rev. volatility 159.34%
EPS volatility 246.96%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na NTHI
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Amir Farrokh Heshmatpour
Employees
5
Headquarters
Calabasas
Nadcházející události
12 LIS
Earnings
Upcoming earnings report